Erschienen in:
21.01.2016
Analysis of catheter contact force during atrial fibrillation ablation using the robotic navigation system: results from a randomized study
verfasst von:
Antonio Dello Russo, Gaetano Fassini, Sergio Conti, Michela Casella, Antonio Di Monaco, Eleonora Russo, Stefania Riva, Massimo Moltrasio, Fabrizio Tundo, Giuseppe De Martino, G. Joseph Gallinghouse, Luigi Di Biase, Andrea Natale, Claudio Tondo
Erschienen in:
Journal of Interventional Cardiac Electrophysiology
|
Ausgabe 2/2016
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Contact with cardiac tissue is an important determinant of lesion efficacy during atrial fibrillation (AF) ablation. The Sensei X™ robotic navigation system (RNS) (Hansen Medical, Mountain View, CA, USA) has been validated for contact force (CF) sensing expressed in grams (g). The Thermocool® SmartTouch™ catheter enables the measurement of catheter tip CF and direction inside the heart. We aimed to investigate the catheter CF with and without RNS during pulmonary vein isolation (PVI) procedures.
Methods
Eighty patients with symptomatic AF (56 males, age 63 ± 18) were enrolled in this study. Fifty-seven patients had paroxysmal AF and 23 early persistent AF. All procedures were performed with the Thermocool® SmartTouch™ ablation catheter. Forty patients were randomized to perform PVI with the Sensei X™ RNS (group 1), while in the other 40 patients (group 2), PVI was performed without the RNS.
Results
AF ablation was performed successfully in all patients without complications, while contact force was kept in the established 10–40 g range. A significantly higher CF was documented on the PVs in group 1 compared to group 2. The 1-year freedom from AF recurrence was higher in group 1 compared to group 2 (90 vs. 65 %, p = 0.04). Moreover, a significant reduction of fluoroscopy time was noted in the RNS group (13 ± 10 vs. 20 ± 10 min, respectively, p = 0.05).
Conclusions
The Sensei X™ RNS permits a significantly higher CF during transcatheter AF ablation with a low rate of AF recurrence at clinical follow-up.